OTC · Financial Statements
Pharmadrug Inc. (LMLLF) Financial Statements
$0.01
OTC: LMLLF
Market Cap $993184
Overview Financials Dividend Pharmadrug Inc. most recently reported annual revenue of $0, net profit of $0. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.
Annual Financials (USD)
Metric 2021 2022 2023 2024 2025 Revenue $0 $0 $0 $0 $0 Operating Profit $-3.0M $-2.0M $-1.0M $-1.0M $0 Net Profit $-6.0M $-9.0M $-13.0M $-1.0M $0 EPS $-0.12 $-0.06 $-0.23 $-0.01 $0.00 Op Margin -38578.1% — — — —
Balance Sheet (USD)
Metric 2021 2022 2023 2024 2025 Total Assets $20.0M $12.0M $1.0M $1.0M $1.0M Total Liabilities $3.0M $3.0M $3.0M $2.0M $2.0M Cash $1.0M $0 $0 $0 $0 Borrowings $1.0M $1.0M $2.0M $1.0M $2.0M
Cash Flow (USD)
Metric 2021 2022 2023 2024 2025 Operating Cash Flow $-4.0M $-2.0M $-1.0M $-1.0M $0 Investing Cash Flow $1.0M $0 $1.0M $0 $0 Financing Cash Flow $1.0M $0 $0 $0 $0 Net Cash Flow $-1.0M $-1.0M $1.0M $0 $0 Free Cash Flow $-4.0M $-2.0M $-1.0M $-1.0M $0
Valuation & Return Ratios
Metric Value PEG Ratio -0.02 EV / EBITDA — FCF Yield 0.00% Quick Ratio 0.20 Interest Coverage — Return 1Y — Return 3Y — Return 5Y —
Screens featuring this stock